Dena Marrinucci News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Truvian Health Presents Multi-Site Clinical Study Data on Its Benchtop Blood Testing Platform to Enable Central Laboratory Quality Results Anywhere

Truvian Health Presents Multi-Site Clinical Study Data on Its Benchtop Blood Testing Platform to Enable Central Laboratory Quality Results Anywhere
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJake robisonAjay srinivasanDena marrinucciTruvian healthClinical chemistry annual scientificClinical chemistry annual scientific meetingTruvian platform

Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System

Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System - read this article along with other careers information, tips and advice on BioSpace

United statesNew delhiMechanical engineeringDainippon sumitomo pharmaEric ziegerDena marrinucciJoe bensonAjay bansalJeff hawkinsAjay srinivasanTyler jensenTruvian sciencesHead of business development at urovant sciencesVirginia universityRady school of managementDesign engineering technology

Stock Market | Daily Herald

Stock Market | Daily Herald
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

United statesNew delhiMechanical engineeringDainippon sumitomo pharmaEric ziegerDena marrinucciJoe bensonAjay bansalJeff hawkinsAjay srinivasanTyler jensenTruvian sciencesHead of business development at urovant sciencesVirginia universityRady school of managementDesign engineering technology

Truvian raises $105M, plans to submit benchtop blood-testing tech to FDA

Truvian raises $105M, plans to submit benchtop blood-testing tech to FDA Benchtop blood testing startup Truvian raised $105 million in series C funding, which it plans to use to pave the way to submit its device for FDA clearance. Shares0 Truvian Sciences plans to seek FDA clearance and CLIA certification for its benchtop blood testing device. Photo credit: Truvian Sciences Truvian Sciences, a startup building a benchtop blood analyzer, raised $105 million in funding. The San Diego-based company plans to use the funds to seek 510(k) clearance and a CLIA waiver from the Food and Drug Administration, with plans to make its first regulatory submission before the end of the year. The company will also look to double its 87-person team, including its recent hire of Jay Srinivasan, former vice president of automation and informatics at Abbott.

Glen tullmanJeff hawkinsDena marrinucciGreg wassonAjay srinivasanMegh guptaOr crossover healthTruvian sciencesWalgreens boots allianceEpic sciencesDrug administrationSan diego basedWittington venturesWittington ventures partner meghOne medicalWeight loss